Bellevue Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Sell |
37,765
-6,141
| -14% | -$3.09M | 0.43% | 54 |
|
|
2025
Q4 | $20.5M | Sell |
43,906
-21,701
| -33% | -$10.1M | 0.39% | 51 |
|
|
2025
Q3 | $28M | Sell |
65,607
-33,515
| -34% | -$13M | 0.58% | 42 |
|
|
2025
Q2 | $38M | Buy |
99,122
+37,315
| +60% | +$13.4M | 0.84% | 30 |
|
|
2025
Q1 | $21.4M | Sell |
61,807
-76
| -0.1% | -$24.4K | 0.48% | 48 |
|
|
2024
Q4 | $18.6M | Sell |
61,883
-52,642
| -46% | -$18.4M | 0.36% | 64 |
|
|
2024
Q3 | $46.5M | Sell |
114,525
-7,779
| -6% | -$2.85M | 0.75% | 35 |
|
|
2024
Q2 | $39.3M | Sell |
122,304
-37,399
| -23% | -$12.2M | 0.64% | 46 |
|
|
2024
Q1 | $53.3M | Buy |
159,703
+7,525
| +5% | +$2.3M | 0.81% | 34 |
|
|
2023
Q4 | $41.2M | Sell |
152,178
-3,465
| -2% | -$856K | 0.63% | 51 |
|
|
2023
Q3 | $38.3M | Sell |
155,643
-4,872
| -3% | -$1.33M | 0.62% | 48 |
|
|
2023
Q2 | $48.7M | Sell |
160,515
-143,271
| -47% | -$39.8M | 0.69% | 48 |
|
|
2023
Q1 | $80.1M | Sell |
303,786
-27,520
| -8% | -$6.99M | 1.16% | 29 |
|
|
2022
Q4 | $79.5M | Buy |
331,306
+45,517
| +16% | +$10.2M | 1.06% | 28 |
|
|
2022
Q3 | $52.5M | Sell |
285,789
-6,982
| -2% | -$1.39M | 0.75% | 41 |
|
|
2022
Q2 | $49.2M | Sell |
292,771
-7,426
| -2% | -$1.6M | 0.7% | 47 |
|
|
2022
Q1 | $75.2M | Buy |
300,197
+5,763
| +2% | +$1.45M | 0.87% | 41 |
|
|
2021
Q4 | $75.6M | Sell |
294,434
-47,039
| -14% | -$11.5M | 0.78% | 42 |
|
|
2021
Q3 | $82.9M | Buy |
341,473
+7,200
| +2% | +$1.76M | 0.84% | 40 |
|
|
2021
Q2 | $69.1M | Sell |
334,273
-40,290
| -11% | -$8.21M | 0.67% | 51 |
|
|
2021
Q1 | $70.5M | Buy |
374,563
+7,519
| +2% | +$1.33M | 0.75% | 46 |
|
|
2020
Q4 | $60.4M | Buy |
367,044
+21,959
| +6% | +$3.21M | 0.69% | 42 |
|
|
2020
Q3 | $43M | Buy |
345,085
+1,919
| +0.6% | +$238K | 0.59% | 48 |
|
|
2020
Q2 | $33.3M | Buy |
343,166
+70,200
| +26% | +$7.3M | 0.47% | 55 |
|
|
2020
Q1 | $24.5M | Buy |
272,966
+20,338
| +8% | +$2.63M | 0.48% | 56 |
|
|
2019
Q4 | $37.3M | Buy |
252,628
+41,246
| +20% | +$5.54M | 0.59% | 45 |
|
|
2019
Q3 | $25.5M | Buy |
211,382
+24,637
| +13% | +$3.18M | 0.47% | 48 |
|
|
2019
Q2 | $25.2M | Buy |
186,745
+126,348
| +209% | +$16M | 0.43% | 53 |
|
|
2019
Q1 | $7.88M | Buy |
60,397
+13,363
| +28% | +$1.79M | 0.43% | 65 |
|
|
2018
Q4 | $5.85M | Buy |
47,034
+10,146
| +28% | +$1.36M | 0.38% | 62 |
|
|
2018
Q3 | $5.13M | Buy |
36,888
+17,888
| +94% | +$2.23M | 0.33% | 70 |
|
|
2018
Q2 | $1.95M | Sell |
19,000
-2,300
| -11% | -$233K | 0.17% | 89 |
|
|
2018
Q1 | $2.07M | Hold |
21,300
| – | – | 0.2% | 77 |
|
|
2017
Q4 | $1.87M | Hold |
21,300
| – | – | 0.2% | 84 |
|
|
2017
Q3 | $1.7M | Hold |
21,300
| – | – | 0.18% | 90 |
|
|
2017
Q2 | $1.86M | Hold |
21,300
| – | – | 0.22% | 82 |
|
|
2017
Q1 | $1.9M | Sell |
21,300
-2,500
| -11% | -$208K | 0.25% | 80 |
|
|
2016
Q4 | $1.76M | Sell |
23,800
-7,400
| -24% | -$554K | 0.36% | 68 |
|
|
2016
Q3 | $2.36M | Sell |
31,200
-12,500
| -29% | -$957K | 0.43% | 66 |
|
|
2016
Q2 | $3.37M | Sell |
43,700
-16,300
| -27% | -$1.29M | 0.63% | 50 |
|
|
2016
Q1 | $4.68M | Buy |
+60,000
| New | +$4.19M | 0.85% | 43 |
|
Other funds holding HCA
VCM
VPM
Bellevue Group's HCA Position: Q1 2026 in Review
Bellevue Group reduced its HCA Healthcare (HCA) stake by 14% in Q1 2026, selling an estimated $3.09M and leaving 37,765 shares worth $17.9M. The position accounts for 0.43% of the portfolio, ranked #54.
Bellevue Group first reported a position in HCA in Q1 2016 and has held it in 41 quarters since. The position peaked at $82.9M in Q3 2021. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Bellevue Group held 37,765 shares of HCA Healthcare worth $17.9M as of Q1 2026.
- Bellevue Group sold 6,141 HCA Healthcare shares in Q1 2026, an estimated $3.09M.
- HCA Healthcare made up 0.43% of Bellevue Group's portfolio in Q1 2026, its #54 holding.
- Bellevue Group first reported a position in HCA Healthcare in Q1 2016 and has held it in 41 quarters since.
- Bellevue Group's HCA Healthcare position peaked at $82.9M in Q3 2021.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.